Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

BACKGROUND: Capecitabine is an established treatment alternative to intravenous 5-fluorouracil (5-FU) for patients with rectal cancer receiving chemoradiotherapy. Its place in the treatment of locally advanced anal carcinoma (AC), however, remains undetermined. We investigated whether capecitabine i...

Descripción completa

Detalles Bibliográficos
Autores principales: Meulendijks, D, Dewit, L, Tomasoa, N B, van Tinteren, H, Beijnen, J H, Schellens, J H M, Cats, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453727/
https://www.ncbi.nlm.nih.gov/pubmed/25167226
http://dx.doi.org/10.1038/bjc.2014.467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453727/
https://www.ncbi.nlm.nih.gov/pubmed/25167226
http://dx.doi.org/10.1038/bjc.2014.467

Ejemplares similares